Literature DB >> 19896746

Global estimates of the prevalence of diabetes for 2010 and 2030.

J E Shaw1, R A Sicree, P Z Zimmet.   

Abstract

AIM: We estimated the number of people worldwide with diabetes for the years 2010 and 2030.
METHODS: Studies from 91 countries were used to calculate age- and sex-specific diabetes prevalences, which were applied to national population estimates, to determine national diabetes prevalences for all 216 countries for 2010 and 2030. Studies were identified using Medline, and contact with all national and regional International Diabetes Federation offices. Studies were included if diabetes prevalence was assessed using a population-based methodology, and was based on World Health Organization or American Diabetes Association diagnostic criteria for at least three separate age-groups within the 20-79 year range. Self-report or registry data were used if blood glucose assessment was not available.
RESULTS: The world prevalence of diabetes among adults (aged 20-79 years) will be 6.4%, affecting 285 million adults, in 2010, and will increase to 7.7%, and 439 million adults by 2030. Between 2010 and 2030, there will be a 69% increase in numbers of adults with diabetes in developing countries and a 20% increase in developed countries.
CONCLUSION: These predictions, based on a larger number of studies than previous estimates, indicate a growing burden of diabetes, particularly in developing countries. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19896746     DOI: 10.1016/j.diabres.2009.10.007

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  1965 in total

Review 1.  Hyperspectral imaging in diabetic foot wound care.

Authors:  Dmitry Yudovsky; Aksone Nouvong; Laurent Pilon
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

2.  Glucose and metformin modulate human first trimester trophoblast function: a model and potential therapy for diabetes-associated uteroplacental insufficiency.

Authors:  Christina S Han; Melissa A Herrin; Mary C Pitruzzello; Melissa J Mulla; Erika F Werner; Christian M Pettker; Clare A Flannery; Vikki M Abrahams
Journal:  Am J Reprod Immunol       Date:  2014-11-14       Impact factor: 3.886

Review 3.  Cardiovascular impact of drugs used in the treatment of diabetes.

Authors:  Chris R Triggle; Hong Ding
Journal:  Ther Adv Chronic Dis       Date:  2014-11       Impact factor: 5.091

Review 4.  Computer-assisted versus oral-and-written dietary history taking for diabetes mellitus.

Authors:  Igor Wei; Yannis Pappas; Josip Car; Aziz Sheikh; Azeem Majeed
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

Review 5.  [Diabetic maculopathy and retinopathy. Functional and sociomedical significance].

Authors:  J G Garweg; A Wenzel
Journal:  Ophthalmologe       Date:  2010-07       Impact factor: 1.059

Review 6.  Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.

Authors:  Yan Zheng; Sylvia H Ley; Frank B Hu
Journal:  Nat Rev Endocrinol       Date:  2017-12-08       Impact factor: 43.330

Review 7.  Initial Weight Loss Response as an Indicator for Providing Early Rescue Efforts to Improve Long-term Treatment Outcomes.

Authors:  Jessica L Unick; Christine A Pellegrini; Kathryn E Demos; Leah Dorfman
Journal:  Curr Diab Rep       Date:  2017-09       Impact factor: 4.810

8.  Left atrium passive ejection fraction is the most sensitive index of type 2 diabetes mellitus-related cardiac changes.

Authors:  Yongning Shang; Xiaochun Zhang; Weiling Leng; Xiaotian Lei; Liu Chen; Ziwen Liang; Jian Wang
Journal:  Int J Cardiovasc Imaging       Date:  2017-07-18       Impact factor: 2.357

Review 9.  Contemporary narrative review on left atrial strain mechanics in echocardiography: cardiomyopathy, valvular heart disease and beyond.

Authors:  Vardhmaan Jain; Raktim Ghosh; Manasvi Gupta; Yoshihito Saijo; Agam Bansal; Medhat Farwati; Rachel Marcus; Allan Klein; Bo Xu
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

Review 10.  Clinical significance of glycated hemoglobin in the acute phase of ST elevation myocardial infarction.

Authors:  Chiara Lazzeri; Serafina Valente; Marco Chiostri; Maria Grazia D'Alfonso; Gian Franco Gensini
Journal:  World J Cardiol       Date:  2014-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.